News

Vizibl Enters Phase I Partnership with Sanofi

September 15, 2020

Vizibl and Sanofi have entered into a Phase I partnership to streamline processes around supplier management.

Thermo Fisher to Invest More than $140 Million into its Lab Plastics Consumables for COVID-19 Testing

September 15, 2020

In addition to increasing production, Thermo Fisher will create 1000 jobs across its global manufacturing sites to further automation capabilities and optimize warehouse and sterilization capacity.

DuPont Rebrands Healthcare Products as DuPont Liveo

September 15, 2020

A new brand name for its silicone healthcare solutions represents DuPont’s dedication to the creation of next-generation, innovative silicone solutions.

Merck Announces Two Oncology Collaborations with Seattle Genetics

September 15, 2020

The companies will focus on the development and commercialization of Seattle Genetics’ ladiratuzumab vedotin and TUKYSA (tucatinib).

Cytiva Invests $500 Million Over 5 years to Expand Global Capacity

September 14, 2020

The investment will include new manufacturing lines and increased automation to deliver additional manufacturing capacity.

Vectura and Monash University to Develop Inhaled Oxytocin for the Prevention of Postpartum Hemorrhage

September 14, 2020

Vectura will support the product from Phase I through to commercial launch.

Gilead to Acquire Immunomedics for $21 Billion

September 14, 2020

The acquisition will give Gilead access to an anti-cancer antibody drug conjugate in clinical development for treating breast and bladder cancers.

Trump Escalates Drug Pricing War

September 14, 2020

The White House issued an executive order Sunday, Sept. 13, 2020 implementing a policy to link payments for medicines provided through Medicare to prices charged in other industrial countries.

FDA Gives Guidance on Manufacturing During COVID-19

September 14, 2020

The temporary guidance discusses the resumption of normal manufacturing during the COVID-19 pandemic.

AZD1222 Clinical Trials Resume in the UK

September 13, 2020

Clinical trials for AZD1222 coronavirus vaccine resume in the UK as per guidance by MHRA.